showed that skin applications of 9: 10-dimethyl-I :2-benzanthracene induced a bigh incidence of ovarian tumours in inbred or hydrid virgin mice of this strain as compared with three other inbred strains. Marchant (1957) also tested 20-methylcholanthrene in a small number of mice of IF origin and obtained a few microscopical tumours. In a previous paper (Mody, 1960) 0-3, 4-7. 8-1 1, and 12-15 weeks from the date of commencement of painting and from then onwards at 8-weekly intervals until 70 weeks. The organs were examined and the tissues fixed, cut and stained as described by Mody (1960) .
Between 8 and 12 weeks after the start of treatment a batch of 4 mice from each group was used for a dailv three-week study of the vaginal smear.
The groups comprised: (i) Sixty females treated with 9: 10-dimethyl-I :2-benzanthracene (DMB).
(h) Fifty-three females treated with 3 : 4-benzpyrene (BP).
(iii) Thirty-seven females treated with 20-methyleholanthrene (MC Po-st-mortem Appearance of the Ovarie8 At autopsy the treated ovaries were either normal, enlarged or reduced in size, the ovaries on the two sides being often of different sizes. On the whole the ovaries appeared normal to the naked eye until 33 weeks from the start of treatment and from then on showed varying degrees of enlargement culminatina in haemorrhagic or non-haemorrhagic cysts or tumours ; at later ages many ovaries were small and shrunken. In the DB-treated mice, however, the ovaries showed no effect of the paintings but underwent a reduction in size with advancing age comparable to that described for untreated mice (Mody, 1960 (Fig. 13) .
Occurrence of tumours.-The histology of the fully formed tumours has been described above. (Fig. 15) , i.e. the changes characteristic of senility with only minor differences took place (Table III) Mody, 1960.) more frequent at older ages than in normal ovaries of the same ages. Cystic follicles without haemorrhage, anovular follicles and corpora lutea atretica, i.e. atretic follicles containing lipoids (Fekete, 1946) , were occasionally observed while they were rarely observed in normal ovaries. Intact young and old corpora lutea persisted until about 30 weeks after treatment i.e. until 46 weeks of age. Involution commenced within 4 weeks following the beginning of treatment and the content of degenerating (those undergoing early degeneration) and completely degenerated corpora lutea was greater than in normal ovaries, where more hpochrome pigment was present. The old DB-treated ovaries showed fibrous scarring and hyaline degeneration in the walls of small arterioles, these changes being uncommon in normal ovaries. Thus after DB treatment, total loss of follicles and diffuse and thecal luteinisation were absent (Fig. 4) . Prorninence of the germinal epithelium was noted with age but proliferation and invaginations were less evident than in normal ovaries. Senile atrophy was seen in 20 of the mice treated with DB, the number of pinhead or greatly reduced ovaries being larger than in normal mice. Uterus
On microscopical examination, the state of the uterus was classed as atrophic, normal or having cystic hyperplasia. In 60 DMB-treated mice, ovarian tumours were present in 12 and cystic hyperplasia occurred in 5 of these (Table IV) (Mody, 1960) . Further evidence is necessary to substantiate this.
Mammary Tumour8
Of 60 DMB-treated mice, ovarian and breast tumours were coincident in 9 out of 12, whereas breast tumours occurred in the absence of ovarian tumours in 6 out of 48 mice (Table IV) . In BP-treated mice, none of the 4 ovarian tumours was associated with a breast tumour. Twelve MC-and 9 DB-induced breast tumours occurred in the absence of ovarian tumours. Thus, although there was a high association between breast and ovarian tumours in DMB-treated mice, this association did not hold for the other 3 carcinogens. Howell et al. (1954) found that DMB-induced ovarian and breast tumours were dissociated, the distribution being random.
DISCUSSION
Incidence of ovarian tumour8 The occurrence of 12 ovarian tumours in 60 IF mice following treatment with DMB is a lower incidence than that of 53 out of 88 previously reported by Howell et al. (1954) . In the present experiments the mice were killed at pre-determined intervals and it is to be expected that the incidence would have been higher had the animals been allowed full survival. Ovarian tumours induced by BP have not been reported previously. No unequivocal tumours were obtained with MC or DB, although pre-tumourous changes followed treatment with MC. Sequence of ovarian changes
The first ovarian effect of DMB, BP or MC is damage to the ovum and this is followed by degeneration of all the existing follicles and failure of new folhcles to develop. These effects are rather more rapid with DMB than with the other two chemicals. Abnormalities of luteinisation are followed by the appearance of iiodules ( Fig. 9 and 10 (Table IV) , and it was also present in the one mouse with a large BP-induced tumour. However, it is an inconstant feature and can only be regarded as a crude index of secretory activity, depending on the ratio of oestrogen to progesterone rather than upon actual quantities. When the BP-induced tumour was grafted into male mice evidence of a feminising effect was seen in lobular development in the breast, suppression of spermatogenesis and lack of secretion in the seminal vesicles.
SUMMARY
Limited skin applications of four carcinogens (DMB, BP, MC and DB) were made to inbred virgin IF mice, which were subsequently killed at ages ranging from 16 to 70 weeks in order that the sequence of ovarian changes might be studied.
Ovarian tumours of the granulosa-cell series were induced by means of DMB and BP, but not with MC or DB. The induction period was shorter with DMB. Pre-tumorous changes were induced with MC, but DB exerted no effect upon the ovary.
The tumours were unilateral and of the granulosa cell series, the granulosa cell type being predominant. They resembled those occurring spontaneously in some strains of mice, those induced by X-irradiation or in intrasplenic ovarian grafts in castrates and the granulosa cell tumours of the human ovary.
The sequence of histological changes in the ovary after treatment with DMB, BP or MC is death of the ova and degeneration of all the follicles, failure of new follicles to develop, merging of the corpora lutea, proliferation and luteinisation of theca cells and formation of multifocal nodules from these luteinised theca cells in one or both ovaries. The tumours arise unilaterally in one or more nodules, the remainder of which undergo regression. The secondary proliferation and luteinisation of the theca cells following merging of the corpora lutea, with subsequent nodule formation, is regarded as the essential precursor of tumour formation. The ovary contralateral to the tumour-bearing ovary, or both ovaries where no tumour is present, undergoes reduction in size. This is characterised by a streaming into the substance of the ovary of dark staining cells derived from the germinal epithelium and the accumulation of lipochrome pigment in phagocytes.
Following treatment with DB the normal age changes which take place in virgins occur (Mody, 1960) . Large cystic follicles, persistent corpora lutea, fibrous scars and hyaline degeneration of blood vessel walls are more frequent than in the normal and some ovaries become greatly reduced in size.
